Amgen outperformed expectations in the fourth quarter of 2024, but revealed an FDA hold on early-stage obesity asset AMG 513 ...

Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Meanwhile, it booked another $2 billion from Xgeva, a higher-dose denosumab-based product ... its osteoporosis franchise with UCB-partnered Evenity (romosozumab), an anti-sclerostin antibody ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

As a result, ivermectin exposure in children following a 200 µg/kg dose is ∼30% lower than in adults. An increased dose of 250 and 300 µg/kg would be needed in school-aged children (6–12 years) and ...

These side effects may be common or severe. There is insufficient scientific evidence to establish a safe or effective dose of DMAE. Always speak with a healthcare provider before taking a supplement ...

After hours: 7:59:58 p.m. EST ...